Opsens Inc

Healthcare CA OPS

NoneCAD
-(-%)

Last update at 2024-01-23T20:03:10.599385Z

Day Range

--
LowHigh

52 Week Range

1.362.90
LowHigh

Fundamentals

  • Previous Close -
  • Market Cap335.47M
  • VolumeNone
  • P/E Ratio-
  • Dividend Yield-%
  • EBITDA-11.51834M
  • Revenue TTM48.35M
  • Revenue Per Share TTM0.43
  • Gross Profit TTM 17.80M
  • Diluted EPS TTM-0.11

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Financials

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2023-08-31 2022-08-31 2021-08-31 2020-08-31 2019-08-31
Type yearly yearly yearly yearly yearly
Date 2023-08-31 2022-08-31 2021-08-31 2020-08-31 2019-08-31
Income before tax -12.12469M -11.33454M -1.12924M -2.64380M -1.95181M
Minority interest - - - - -
Net income -12.40250M -11.37823M -1.15043M -2.64389M -1.96239M
Selling general administrative 29.19M 7.82M 6.47M 5.04M 4.59M
Selling and marketing expenses - 12.58M 7.65M 8.78M 11.12M
Gross profit 27.97M 17.80M 18.68M 15.62M 18.72M
Reconciled depreciation 2.10M 1.82M 1.77M 1.67M 0.89M
Ebit - -10.68303M -0.10196M -1.81064M -1.59461M
Ebitda - -8.86549M 1.67M -0.14315M -0.70118M
Depreciation and amortization - 1.82M 1.77M 1.67M 0.89M
Non operating income net other - - - - -
Operating income -12.52411M -10.68303M -0.10196M -1.81064M -1.59461M
Other operating expenses - 46.28M 35.42M 33.10M 34.55M
Interest expense 0.72M 0.58M 0.75M 0.83M 0.35M
Tax provision 0.28M 0.04M 0.02M - -
Interest income 0.69M 0.27M 0.11M 0.15M 0.20M
Net interest income -0.02939M -0.31149M -0.63712M -0.68398M -0.14597M
Extraordinary items - - - - -
Non recurring - - - - -
Other items - - - - -
Income tax expense - 0.04M 0.02M 0.00009M 0.01M
Total revenue 48.35M 35.32M 34.46M 29.45M 32.75M
Total operating expenses 60.87M 28.76M 19.63M 19.26M 20.51M
Cost of revenue 20.37M 17.52M 15.78M 13.83M 14.04M
Total other income expense net 0.43M -0.65151M -1.02728M -0.83316M -0.35720M
Discontinued operations - - - - -
Net income from continuing ops -12.40250M -11.37823M -1.15043M -2.64380M -1.95181M
Net income applicable to common shares - -11.37823M -1.15043M -2.64380M -1.95181M
Preferred stock and other adjustments - - - - -
Breakdown 2023-08-31 2022-08-31 2021-08-31 2020-08-31 2019-08-31
Type yearly yearly yearly yearly yearly
Date 2023-08-31 2022-08-31 2021-08-31 2020-08-31 2019-08-31
Total assets 50.83M 48.51M 58.51M 31.91M 30.09M
Intangible assets 1.68M 1.79M 1.68M 1.62M 1.03M
Earning assets - - - - -
Other current assets - 1.75M 0.65M 0.58M 0.70M
Total liab 17.00M 14.25M 16.18M 16.56M 12.65M
Total stockholder equity 33.83M 34.26M 42.33M 15.35M 17.44M
Deferred long term liab - - - - -
Other current liab 1.96M 4.93M 3.07M 2.28M 2.27M
Common stock - 85.94M 82.89M 54.77M 54.71M
Capital stock 97.03M 85.94M 82.89M 54.77M 54.71M
Retained earnings -68.17618M -55.77368M -44.39545M -43.24502M -40.67806M
Other liab - - - - 0.73M
Good will - - - - -
Other assets - - - - -
Cash 18.10M 23.82M 38.56M 10.88M 14.86M
Cash and equivalents - 21.19M - - -
Total current liabilities 8.78M 8.60M 7.39M 5.66M 4.79M
Current deferred revenue - 0.20M 0.12M 0.05M 0.93M
Net debt - -17.13188M -26.44814M 1.93M -7.36166M
Short term debt - 1.03M 3.33M 1.91M 0.36M
Short long term debt 0.51M 0.47M 2.80M 1.46M 0.36M
Short long term debt total - 6.68M 12.12M 12.81M 7.49M
Other stockholder equity - 4.09M 3.82M 3.82M 3.41M
Property plant equipment - 7.71M 7.05M 7.74M 2.96M
Total current assets 38.76M 39.02M 49.78M 22.54M 26.10M
Long term investments - - - - -
Net tangible assets - 32.47M 40.65M 13.72M 16.41M
Short term investments - - 35.86M 7.63M 13.58M
Net receivables 8.93M 6.78M 4.46M 4.58M 5.41M
Long term debt 1.32M 0.64M 4.59M 6.61M 7.14M
Inventory 9.57M 6.67M 6.12M 6.51M 5.13M
Accounts payable 2.21M 2.44M 0.88M 1.42M 2.16M
Total permanent equity - - - - -
Noncontrolling interest in consolidated entity - - - - -
Temporary equity redeemable noncontrolling interests - - - - -
Accumulated other comprehensive income - -0.00214M 0.00866M -5.42984M -4.61738M
Additional paid in capital - - - - -
Common stock total equity - - - 54.77M 54.71M
Preferred stock total equity - - - - -
Retained earnings total equity - - - - -
Treasury stock - - - - -
Accumulated amortization - - - - -
Non currrent assets other - - - - 3.99M
Deferred long term asset charges - - - - -
Non current assets total 12.07M 9.50M 8.73M 9.37M 3.99M
Capital lease obligations 7.38M 5.57M 4.72M 4.75M -
Long term debt total - 5.65M 8.79M 10.91M 7.14M
Breakdown 2023-08-31 2022-08-31 2021-08-31 2020-08-31 2019-08-31
Type yearly yearly yearly yearly yearly
Date 2023-08-31 2022-08-31 2021-08-31 2020-08-31 2019-08-31
Investments -1.84727M -0.97284M -0.93746M -1.76525M -1.00432M
Change to liabilities - 3.04M 0.21M -0.53611M 1.60M
Total cashflows from investing activities - -0.97284M -0.93746M -1.76525M -1.00432M
Net borrowings - -6.82568M -1.16224M -0.53797M 6.25M
Total cash from financing activities 10.46M -5.01083M 25.88M -1.21109M 6.24M
Change to operating activities - -1.39876M 0.29M -0.29147M -0.28853M
Net income -12.40250M -11.37823M -1.15043M -2.64380M -1.95181M
Change in cash -5.71188M -14.74678M 27.68M -3.97196M 3.97M
Begin period cash flow 23.82M 38.56M 10.88M 14.86M 10.89M
End period cash flow 18.10M 23.82M 38.56M 10.88M 14.86M
Total cash from operating activities -14.46429M -8.78135M 2.84M -0.98506M -1.24717M
Issuance of capital stock 12.04M 2.16M 29.79M 0.03M 0.23M
Depreciation 2.10M 1.82M 1.77M 1.67M 0.89M
Other cashflows from investing activities - 0.24M 0.10M 0.15M 0.20M
Dividends paid 0.00000M 0.00000M 0.00000M 0.00000M 0.00000M
Change to inventory -2.89379M -0.55709M 0.39M -1.37204M 0.09M
Change to account receivables -3.18167M -1.71985M -0.09437M 1.05M -2.26996M
Sale purchase of stock - 2.16M 29.79M 0.03M 0.23M
Other cashflows from financing activities - -0.34160M -1.91267M -0.46371M 6.68M
Change to netincome - 1.42M 1.40M 1.15M 0.68M
Capital expenditures 2.54M 1.21M 1.03M 1.91M 1.20M
Change receivables - - - - -
Cash flows other operating - - - - -
Exchange rate changes - - - - -
Cash and cash equivalents changes - - - - -
Change in working capital -5.09243M -0.64396M 0.81M -1.15446M -0.87279M
Stock based compensation 1.22M 1.16M 0.46M 0.44M 0.49M
Other non cash items -0.07262M 0.26M 0.94M 0.71M 0.19M
Free cash flow -17.00383M -9.98987M 1.80M -2.89553M -2.45119M

Peer Comparison

Sector: Healthcare Industry: Medical Instruments & Supplies

Company Change (CAD) Price (CAD) Trailing PE (x) Forward PE (x) Price Sales TTM (x) Price to Book Value (x) Enterprise Value to Revenue (x) Enterprise Value to EBITDA (x)
OPS
Opsens Inc
- -% - - 56.18 6.94 9.92 6.75 -35.1194
BLCO
Bausch + Lomb Corp
-0.14 0.88% 15.85 - 17.36 2.09 1.07 2.42 20.09

Reports Covered

Stock Research & News

Profile

Opsens Inc. develops, manufactures, installs, and sells fiber optic sensors for cardiovascular interventions. The company operates in two segments, Medical and Industrial. The company provides advanced optical-based pressure guidewire (OptoWire), a guidewire used in the transcatheter aortic valve replacement procedure; and a range of miniature optical sensors to measure pressure and temperature to be used in a range of applications that can be integrated in other medical devices. It also develops, manufactures, and markets medical products; and offers OPP-GD fiber optic differential pressure sensors and the OEC fiber optic extensometer sensors. The company serves life sciences, energy, defense and aerospace, geotechnical, civil engineering, scientific laboratory, and various other markets. The company sells its products through a network of distributors and direct sales force in the United States, Japan, Canada, and internationally. Opsens Inc. was formerly known as Capital DCB inc. and changed its name to OpSens Inc. in October 2006. The company was founded in 2003 and is headquartered in Québec, Canada. As of December 12, 2023, Opsens Inc. operates as a subsidiary of Haemonetics Corporation.

Opsens Inc

750 Boulevard du Parc Technologique, Québec, QC, Canada, G1P 4S3

Key Executives

Name Title Year Born
Mr. Alan W. Milinazzo Exec. Chairman 1960
Mr. Louis Laflamme C.A., C.P.A., CPA Pres, CEO, Interim CFO & Director NA
Mr. Brad Davis Chief Commercial Officer NA
Mr. Pierre Poulin Corp. Controller NA

Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.